Rozanolixizumab (RYSTIGGO) is a high-affinity humanized immunoglobulin G4 monoclonal antibody targeting Fc receptors (FcRn) in human newborns for the study of pathogenic IgG in autoimmune and alloimmune diseases.
Purity:
95.90%
CAS Number:
[1584645-37-3]
Target:
Others|||TNF
T39057
* VAT and and shipping costs not included. Errors and price changes excepted